The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer

British Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 588-592

  Jansson, O T ^a   Morcos, E ^a   Brundin, L ^a   Lundberg, J O N ^b   Adolfsson, J ^a   Soderhall M ^a   Wiklund, N P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bacillus Calmette Gu rin; Bladder cancer; Nitric oxide; Nitric oxide donor; Nitric oxide synthase

Indexed keywords

BCG VACCINE; CALCIUM; CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, PAPILLARY; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0031878508     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.545     Document Type: Article

References (21)

1. Andrade SP, Hart IR and Piper PJ (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 107: 1092-1095
2. Cilento BG, Freeman MR, Schneck FX, Retik AB and Atala A (1994) Phenotypic and cytogenic characterization of human bladder urothelia expanded in vitro. J Urol 152: 665-670
3. Ehrén I, Hammarström M, Adolfsson J and Wiklund NP (1995) Induction of calcium-dependent nitric oxide synthase by sex hormones in the guinea-pig urinary bladder. Acta Physiologica Scand 153: 393-394
4. Farias-Eisner R, Sherman MP, Aerberhard E and Chaudhuri G (1994) Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci USA 91: 9407-9411
5. Fleischmann JD, Toossi Z, Ellner JJ, Wentworth DB, Ratliff TL and Imbemo AL (1989) Urinary interleukins in patients receiving intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Cancer 64: 1447-1454
6. Hibbs JB Jr, Taintor RR, Vavrin Z, Granger DL, Drapier J-C, Amber IJ and Lancaster JR Jr (1990) Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In Nitric oxide from L-arginine: a bioregulatory system: Proceedings of the Symposium on Biological Importance of Nitric Oxide, Moncada S and Higgs A (eds), pp. 189-223. Elsevier: Amsterdam
7. Jackson AM and James K (1994) Understanding the most successful immunotherapy for cancer. The Immunologist 2: 208-215
8. Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, Prescott S, Chisholm GD and James K (1995) Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol 99: 369-375
9. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396
10. Knowles RG and Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298: 249-258
11. Lamm DL (1992) Optimal BCG treatment of superficial bladder cancer as defined by American trials. Eur Urol 21: 12-16
12. Moncada S and Higgs A (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9: 1319-1330
13. Morales A, Eidinger D and Bruce AW (1976) Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116: 180-183
14. Radomski MW, Jenkins DC, Holmes L and Moncada S (1991) Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 51: 6073-6078
15. Ratliff TL, Haaf EO, Catalona WJ (1986) Interleukin-2 production during intravesical bacillus Calmette-Guérin therapy for bladder cancer. Clin Immmunol Immunopathol 40: 375-379
16. Rosenkrantz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA and Pober JS (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. J Clin Invest 93: 2236-2243
17. Thomae KR, Nakayama DK, Billiar TR, Simmons RL, Pitt BR and Davies P (1995) The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res 59: 337-343
18. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V and Moncada S (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354
19. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44
20. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG and Moncada S (1994) Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc Natl Acad Sci USA 91: 5212-5216
21. Wingo PA, Tong T and Bolden S (1995) Cancer statistics. Cancer J Clin 45: 8-30